TAK-733 5mg 5mg | Purity Not Available
Adooq Bioscience
TAK-733 is an orally bioavailable small-molecule inhibitor of MEK1 and MEK2 (MEK1/2) with potential antineoplastic activity.
More Information Supplier PageTAK-733 is an orally bioavailable small-molecule inhibitor of MEK1 and MEK2 (MEK1/2) with potential antineoplastic activity.
More Information Supplier PageTAK-733 is an orally bioavailable small-molecule inhibitor of MEK1 and MEK2 (MEK1/2) with potential antineoplastic activity.
More Information Supplier PageTAK-733 is an orally bioavailable small-molecule inhibitor of MEK1 and MEK2 (MEK1/2) with potential antineoplastic activity.
More Information Supplier PageTubastatin A HCl is a potent HDAC inhibitor that demonstrates over more selectivity than all other HDAC isoforms (IC50s >16 uM), excluding HDAC8 (IC50 = 0.9 M).
More Information Supplier PageTubastatin A HCl is a potent HDAC inhibitor that demonstrates over more selectivity than all other HDAC isoforms (IC50s >16 uM), excluding HDAC8 (IC50 = 0.9 M).
More Information Supplier PageTAK-700 (Orteronel) is an oral, non-steroidal androgen synthesis inhibitor that selectively inhibits the 17,20 lyase enzyme.
More Information Supplier PageTAK-700 (Orteronel) is an oral, non-steroidal androgen synthesis inhibitor that selectively inhibits the 17,20 lyase enzyme.
More Information Supplier PageMG-132 is a potent cell-permeable inhibitor of proteasome (IC50 = 100 nM) and calpain (IC50 = 1.2 ??M).
More Information Supplier PageMG-132 is a potent cell-permeable inhibitor of proteasome (IC50 = 100 nM) and calpain (IC50 = 1.2 ??M).
More Information Supplier PageMG-132 is a potent cell-permeable inhibitor of proteasome (IC50 = 100 nM) and calpain (IC50 = 1.2 ??M).
More Information Supplier Page